Search Results - "Barakat, Maxime"

Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach by McIntyre, Roger S, Filteau, Marie-Josée, Martin, Lawrence, Patry, Simon, Carvalho, Andre, Cha, Danielle S, Barakat, Maxime, Miguelez, Maia

“…Abstract Background Most adults with major depressive disorder (MDD) fail to achieve remission with index pharmacological treatment. Moreover, at least half…”
Get full text

Extended-release naltrexone/bupropion is safe and effective among subjects with type 2 diabetes already taking incretin agents: a post-hoc analysis of the LIGHT trial by Wharton, Sean, Yin, Peter, Burrows, Melonie, Gould, Errol, Blavignac, Jessica, Christensen, Rebecca A. G., Kamran, Elham, Camacho, Fernando, Barakat, Maxime

“…Background Extended-release naltrexone/bupropion (NB) is indicated for chronic weight management. Incretin agents are recommended for patients with type 2…”
Get full text

A randomized, placebo‐controlled study to evaluate safety and pharmacokinetics of inhaled ribavirin by Couroux, Peter, Brkovic, Alexandre, Vittitow, Jason L., Israel, Robert J., Pamidi, Chinna, Patel, Jignesh, Barakat, Maxime

“…Ribavirin is an inosine monophosphate dehydrogenase inhibitor. Studies suggest ribavirin aerosol could be a safe and efficacious treatment option in the fight…”
Get full text

The relationship between early weight loss and weight loss maintenance with naltrexone-bupropion therapy by le Roux, Carel W., Fils-Aimé, Nadège, Camacho, Fernando, Gould, Errol, Barakat, Maxime

“…Extended-release (ER) naltrexone/bupropion (NB) was associated with greater weight loss than placebo in four randomized, 56-week trials. The association of NB…”
Get full text

Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial by Poulakou, Garyfallia, Barakat, Maxime, Israel, Robert J., Bacci, Marcelo R., Abril, Juan Francisco Moreno Hoyos, Álvarez, Samuel Navarro, Fonseca, Fernando Luiz Affonso, Kainis, Ilias, Kalomoiri, Smaragdi, Leontis, Konstantinos, Metallidis, Symeon, Panagopoulos, Periklis, Papastamopoulos, Vasileios, Ragognete, Henrique Gitti, Ramacciotti, Eduardo, Rapti, Vasiliki, Sakka, Vissaria, Syrigos, Konstantinos N., Tsoukalas, George, Xynogalas, Ioannis

“…There is an unmet medical need for effective treatments for hospitalized patients with coronavirus disease 2019 (COVID‐19). Ribavirin is a broad‐spectrum…”
Get full text

Clinico-Virological Outcomes and Mutational Profile of SARS-CoV-2 in Adults Treated with Ribavirin Aerosol for COVID-19 Pneumonia by Morsica, Giulia, Messina, Emanuela, Bagaglio, Sabrina, Galli, Laura, Lolatto, Riccardo, Sampaolo, Michela, Barakat, Maxime, Israel, Robert J, Castagna, Antonella, Clementi, Nicola

“…The emergence of new SARS-CoV-2 variants can affect vaccine efficacy, laboratory diagnosis and the therapies already available, triggering interest in the…”
Get full text

Regional variability in Canadian routine care of type 2 diabetes, hypercholesterolemia, and hypertension: Results from the The Cardio-Vascular and metabolic treatments in Canada: Assessment of REal-life therapeutic value (CV-CARE) registry by Goldenberg, Ronald, Bell, Alan, Cheng, Will, Paron, Emilia, Fils-Aimé, Nadege, Burrows, Melonie, Blavignac, Jessica, Barakat, Maxime

“…•Patient profiles and treatments for type 2 diabetes, hypercholesterolemia, and/or hypertension differ across Canada.•Variabilities in disease treatment…”
Get full text

Real-world treatment outcomes with halobetasol propionate 0.01%/tazarotene 0.045% lotion in patients with mild-to-moderate plaque psoriasis: A Canadian multicenter retrospective chart review by Vender, Ronald, Turchin, Irina, Lansang, Perla, Prajapati, Vimal H., Legault, Mark, Barakat, Maxime, Yeung, Jensen

Get full text

Efficacy of brodalumab in moderate-to-severe plaque psoriasis after failure of previous biologic therapy: A phase 4, multicenter, open-label study by Papp, Kim, Prajapati, Vimal H, Maari, Catherine, Legault, Mark, Barakat, Maxime, Vender, Ronald

Get full text

Brodalumab success in patients with moderate-to-severe psoriasis who failed previous interleukin-17A inhibitors by Yeung, Jensen, Vender, Ron, Turchin, Irina, Shukla, Rahul, Maari, Catherine, Hong, Chih-ho, Barakat, Maxime, Lansang, Perla

Get full text

Psychiatric Safety and Weight Loss Efficacy of Naltrexone/bupropion as Add-on to Antidepressant Therapy in Patients with Obesity or Overweight by McIntyre, Roger S., Paron, Emilia, Burrows, Melonie, Blavignac, Jessica, Gould, Errol, Camacho, Fernando, Barakat, Maxime

“…•In patients with obesity / overweight who are taking antidepressants, extended-release naltrexone/bupropion (NB):•Appears to be safe;•Had significantly…”
Get full text

49513 Effectiveness and Persistence of Brodalumab in Patients with Plaque Psoriasis in the Canadian Real-World Setting: 3-Month Follow-up Results from the CARE Study by Gaudet, Véronique, Wiseman, Marni, Kalia, Sunil, Tuppal, Raj, Prajapati, Vimal H., Gagné-Henley, Angélique, Brown-Maher, Tracey, Barbeau, Martin, Barakat, Maxime, Neish, Calum

Get full text

Extended‐release naltrexone/bupropion and liver health: Pooled, post hoc analysis from four randomized controlled trials by Bajaj, Harpreet S., Burrows, Melonie, Blavignac, Jessica, Paron, Emilia, Camacho, Fernando, Gould, Errol, Barakat, Maxime

“…Sustained weight loss improves liver histology in non‐alcoholic fatty liver disease. This post hoc analysis of four phase III, 56‐week, randomized controlled…”
Get full text

The generalized E-DVA method: a new approach for multi-modal pushover analysis under multi-component earthquakes with local variables maximization by Lherminier, Olivier, Erlicher, Silvano, Huguet, Miquel, Civera, Marco, Ceravolo, Rosario, Barakat, Maxime

“…Pushover analysis is a common nonlinear static procedure, performed to evaluate seismic response of civil structures. This approach allows considering the…”
Get full text

141-OR: Efficacy and Safety of Naltrexone/Bupropion as Add-On to Incretin Agents in Patients with Obesity and T2DM by WHARTON, SEAN, YIN, PETER, CAMACHO, FERNANDO, BURROWS, MELONIE, BLAVIGNAC, JESSICA, BARAKAT, MAXIME

“…There is significant overlap between obesity and type 2 diabetes (T2DM). Incretin agents (dipeptidyl peptidase 4 (DPP-4) inhibitors and glucagon-like peptide 1…”
Get full text

Real-world effectiveness of treatments for type 2 diabetes, hypercholesterolemia, and hypertension in Canadian routine care – Results from the CardioVascular and metabolic treatment in Canada: Assessment of REal-life therapeutic value (CV-CARE) registry, 12-months results by Goldenberg, Ronald, Bell, Alan, Cheng, Willoon, Fils-Aimé, Nadège, Burrows, Melonie, Blavignac, Jessica, Parron, Emilia, Barakat, Maxime

“…•Achieving targets of cardiometabolic disease parameters crucial to delay complications.•RWE of the safety and efficacy of CV and metabolic drugs in Canada is…”
Get full text

Ribavirin Aerosol in the Treatment of SARS-CoV-2: A Case Series by Messina, Emanuela, Danise, Anna, Ferrari, Giulio, Andolina, Andrea, Chiurlo, Matteo, Razanakolona, Marie, Barakat, Maxime, Israel, Robert J., Castagna, Antonella

“…Ribavirin is an inosine monophosphate dehydrogenase inhibitor with demonstrated activity against coronaviruses, including SARS-CoV-2. Five hospitalized…”
Get full text

Improving implementation of best practices in obesity management: Physician experiences in obesity care by Lee‐Baggley, Dayna, Fils‐Aimé, Nadège, Audet, Isabelle, Barakat, Maxime

“…Summary In this study, we sought to analyse experiences in weight management among physicians working in the area of obesity and contrast these experiences…”
Get full text

The i-ACT™ in Obesity educational intervention: a pilot study on improving Canadian family physician care in obesity medicine by Wharton, Sean, Macklin, David, Morin, Marie-Philippe, Blavignac, Jessica, Menzies, Stuart, Garofalo, Laura, Francisco, Michelle A, Thomas, Carol, Barakat, Maxime

“…Obesity is a chronic problem in Canada and although the Canadian Medical Association recognizes obesity as a disease, health care professionals (HCPs) are not…”
Get full text

Real-World Effectiveness of Metformin-ER in Type 2 Diabetes Management From CV-CARE, a Canadian Registry by Bell, Alan, Goldenberg, Ronald, Cheng, Willoon, Karellis, Angela, Sampalis, John, Fortin, Jean-Francois, Blavignac, Jessica, Giguere, Monique, Barakat, Maxime

Get full text